Andon Health Co., Ltd.
002432
Category
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | 5.15 | -51.78% |
| 2024 | 10.69 | -20.85% |
| 2023 | 13.51 | 828.74% |
| 2022 | 1.45 | -94.13% |
| 2021 | 24.79 | 50.36% |
| 2020 | 16.49 | -79.71% |
| 2019 | 81.25 | -51.65% |
| 2018 | 168.07 | -804.49% |
| 2017 | -23.86 | -106.14% |
| 2016 | 388.25 | -744.46% |
| 2015 | -60.24 | -107.88% |
| 2014 | 765.00 | -238.84% |
| 2013 | -551.00 | -329.58% |
| 2012 | 240.00 | 108.81% |
| 2011 | 114.94 | -23.10% |
| 2010 | 149.45 | 135.89% |
| 2009 | 63.36 | -19.05% |
| 2008 | 78.26 | 29.41% |
| 2007 | 60.48 | 0.00% |
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| 47.48 | 821.16% |
US
|
|
| 27.43 | 432.04% |
FR
|
|
| - | - |
JP
|
|
| 56.89 | 1,003.70% |
US
|
|
| - | - |
CH
|
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.